TipRanks
Advertisement
Advertisement
Entera Bio Moves Toward Phase 3 With Oral Therapy That Could Transform Osteoporosis Treatment (NASDAQ: ENTX)
PremiumTipRanks NewswireEntera Bio Moves Toward Phase 3 With Oral Therapy That Could Transform Osteoporosis Treatment (NASDAQ: ENTX)
7M ago
Why Is Impact BioMedical Stock (IBO) Up Today?
Premium
Market News
Why Is Impact BioMedical Stock (IBO) Up Today?
7M ago
Impact BioMedical Amends Merger Terms and Extends Deadline
Premium
Company Announcements
Impact BioMedical Amends Merger Terms and Extends Deadline
7M ago
Why Is Impact BioMedical Stock (IBO) Up 200% Today?
PremiumMarket NewsWhy Is Impact BioMedical Stock (IBO) Up 200% Today?
1y ago
Impact BioMedical Announces Strategic Merger with Dr Ashleys
Premium
Company Announcements
Impact BioMedical Announces Strategic Merger with Dr Ashleys
1y ago
Morning News Wrap-Up: Monday’s Biggest Stock Market Stories!
Premium
Market News
Morning News Wrap-Up: Monday’s Biggest Stock Market Stories!
1y ago
Impact BioMedical Appoints Chan Heng Fai Ambrose as Director
PremiumCompany AnnouncementsImpact BioMedical Appoints Chan Heng Fai Ambrose as Director
2y ago
Impact BioMedical announces acquisition of Celios in $1.15M equity transaction
Premium
The Fly
Impact BioMedical announces acquisition of Celios in $1.15M equity transaction
2y ago
DSS announces sale of Celios to Impact BioMedical
Premium
The Fly
DSS announces sale of Celios to Impact BioMedical
2y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100